NO20031177L - Fremgangsmåter og sammensetninger for glykosidaseanalyser - Google Patents

Fremgangsmåter og sammensetninger for glykosidaseanalyser

Info

Publication number
NO20031177L
NO20031177L NO20031177A NO20031177A NO20031177L NO 20031177 L NO20031177 L NO 20031177L NO 20031177 A NO20031177 A NO 20031177A NO 20031177 A NO20031177 A NO 20031177A NO 20031177 L NO20031177 L NO 20031177L
Authority
NO
Norway
Prior art keywords
compositions
methods
glycosidase assays
glycosidase
assays
Prior art date
Application number
NO20031177A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031177D0 (no
Inventor
Sivaram Pillarisetti
Uday Saxena
Dongyan Wang
Original Assignee
Reddy Us Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddy Us Therapeutics Inc filed Critical Reddy Us Therapeutics Inc
Publication of NO20031177D0 publication Critical patent/NO20031177D0/no
Publication of NO20031177L publication Critical patent/NO20031177L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
NO20031177A 2000-09-15 2003-03-14 Fremgangsmåter og sammensetninger for glykosidaseanalyser NO20031177L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23307500P 2000-09-15 2000-09-15
PCT/US2001/028862 WO2002023197A2 (en) 2000-09-15 2001-09-14 Methods and compositions for glycosidase assays

Publications (2)

Publication Number Publication Date
NO20031177D0 NO20031177D0 (no) 2003-03-14
NO20031177L true NO20031177L (no) 2003-05-14

Family

ID=22875789

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031177A NO20031177L (no) 2000-09-15 2003-03-14 Fremgangsmåter og sammensetninger for glykosidaseanalyser

Country Status (10)

Country Link
US (1) US6656699B2 (pl)
EP (1) EP1356083A2 (pl)
JP (1) JP2004529606A (pl)
AU (1) AU2001294563A1 (pl)
CA (1) CA2426517A1 (pl)
IL (1) IL154904A0 (pl)
MX (1) MXPA03002243A (pl)
NO (1) NO20031177L (pl)
PL (1) PL366012A1 (pl)
WO (1) WO2002023197A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL366012A1 (pl) * 2000-09-15 2005-01-24 Reddy Us Therapeutics, Inc. Kompozycja i sposób oznaczania glikozydazy
EP1385990A4 (en) * 2001-05-09 2004-09-22 Insight Biopharmaceuticals Ltd METHODS AND MATERIALS USING HEPARANASE AS A DIAGNOSTIC MARKER FOR HEMOSTATIC DISORDERS
WO2003011119A2 (en) * 2001-07-31 2003-02-13 Reddy Us Therapeutics, Inc. Methods and compositions for diagnosis and treatment of vascular conditions
WO2005040163A1 (en) 2003-10-28 2005-05-06 Dr. Reddy's Laboratories Ltd Heterocyclic compounds that block the effects of advanced glycation end products (age)
WO2009075774A2 (en) * 2007-12-05 2009-06-18 Massachusetts Institute Of Technology Glycosaminoglycan-coated particles and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859581A (en) 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
EP0532695A1 (en) * 1990-05-31 1993-03-24 Board Of Regents, The University Of Texas System Immunochemical localization of heparanase in mouse and human melanomas
AU7368994A (en) * 1993-07-29 1995-02-28 Upjohn Company, The Use of heparanase to identify and isolate anti-heparanase compound
TW565614B (en) 1996-07-18 2003-12-11 Univ Australian Detection of mammalian heparanase activity and purification of mammalian heparanase
US5968822A (en) 1997-09-02 1999-10-19 Pecker; Iris Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
US6177545B1 (en) 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US6190875B1 (en) 1997-09-02 2001-02-20 Insight Strategy & Marketing Ltd. Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe
EP1032656A4 (en) 1997-10-28 2002-10-29 Univ Australian ISOLATED NUCLEIC ACID MOLECULES, WHICH CODES FOR ENDOGLUCURONIDASE FROM MAMMALS, AND THEIR USE
GB9802725D0 (en) 1998-02-09 1998-04-08 Ciba Geigy Ag Organic compounds
EP1060252A2 (en) 1998-02-24 2000-12-20 PHARMACIA & UPJOHN COMPANY Human platelet heparanase polypeptides, polynucleotide molecules that encode them, and methods for the identification of compounds that alter heparanase activity
EP1157118A4 (en) 1999-03-01 2002-07-17 Insight Strategy & Marketing POLYNUCLEOTID ENCODING A POLYPEPTIDE WITH HEPARANASE ACTIVITY AND ITS EXPRESSION IN GENETICALLY MODIFIED CELLS
GB9913415D0 (en) 1999-06-10 1999-08-11 Central Manchester Healthcare Heparanase assay
PL366012A1 (pl) * 2000-09-15 2005-01-24 Reddy Us Therapeutics, Inc. Kompozycja i sposób oznaczania glikozydazy

Also Published As

Publication number Publication date
WO2002023197A3 (en) 2003-07-24
JP2004529606A (ja) 2004-09-30
WO2002023197A2 (en) 2002-03-21
MXPA03002243A (es) 2004-12-03
US6656699B2 (en) 2003-12-02
IL154904A0 (en) 2003-10-31
NO20031177D0 (no) 2003-03-14
PL366012A1 (pl) 2005-01-24
US20020064806A1 (en) 2002-05-30
CA2426517A1 (en) 2002-03-21
AU2001294563A1 (en) 2002-03-26
EP1356083A2 (en) 2003-10-29

Similar Documents

Publication Publication Date Title
DK1202941T3 (da) Gipssammensætninger og beslægtede fremgangsmåder
EP1298180A4 (en) HYDROPHOBIC AND LIPOPHOBE COMPOSITION
DK1339292T3 (da) Sammensætning og fremgangsmåde
NO20000011D0 (no) Skumdempersammensetninger og fremgangsmåter
IS2932B (is) Fúlvestrant samsetning
NO20013393D0 (no) Brönnsementeringsfremgangsmåter og sammensetninger
ATE303787T1 (de) Schergelzusammensetzungen
AR028197A1 (es) Composiciones antitranspirantes
NO20013356L (no) Forsinkede tiksotropiske sementsammensetninger og fremgangsmåter
IS6915A (is) Lyfjablanda
BR0210619A (pt) composição
IS7081A (is) Lyfjablanda
NO20021786D0 (no) Skumdempningsfremgangsmåter og sammensetninger
DE60144537D1 (de) Kühler
ATE314049T1 (de) Schweisshemmende zusammensetzungen
NO20030848D0 (no) Paroxetinsammensetninger og fremgangsmåter for å lage det samme
DE60109640D1 (de) Kühlvorrichtung
EP1328278A4 (en) GLUCOSAMINE ANALGESIC AND COMPOSITIONS
DE60116858D1 (de) Zusammensetzung
DE50103149D1 (de) Kühlvorrichtung
NO20031177D0 (no) Fremgangsmåter og sammensetninger for glykosidaseanalyser
ITTO20020747A0 (it) Composizione
DE60107312D1 (de) Feste Zusammensetzung
DE50100367D1 (de) Kühlvorrichtung
ITTO20020745A0 (it) Composizione